Standout Papers

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of... 2018 2026 2020 2023 307
  1. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial (2018)
    Zhi‐Wei Lai, Ryan L. Kelly et al. The Lancet

Immediate Impact

6 by Nobel laureates 15 from Science/Nature 58 standout
Sub-graph 1 of 19

Citing Papers

Protein codes promote selective subcellular compartmentalization
2025 StandoutScience
De novo protein design—From new structures to programmable functions
2024 Standout
3 intermediate papers

Works of Ryan L. Kelly being referenced

Nonspecificity in a nonimmune human scFv repertoire
2017
Target-independent variable region mediated effects on antibody clearance can be FcRn independent
2016
and 2 more

Author Peers

Author Last Decade Papers Cites
Ryan L. Kelly 874 558 283 25 1.5k
Ching Chen 614 995 420 31 1.9k
Silke Meister 619 874 158 24 1.7k
K Kaushansky 656 705 131 23 2.1k
Takaichi Shimozato 434 511 137 30 1.2k
Joseph C. Marini 371 738 262 29 1.5k
Eric G. Bremer 805 388 137 19 1.5k
Mark Allegretta 489 985 230 32 1.9k
Deepa Hammaker 847 520 128 39 1.9k
Kartik Raghupathi 391 479 155 22 1.9k
Suzanne J. Suchard 480 584 153 35 1.2k

All Works

Loading papers...

Rankless by CCL
2026